Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT00356720
Eligibility Criteria:
Inclusion Criteria:
* Male or female aged 1-10 years;
* written informed consent by legally acceptable representative;
* TF+ TI0 (trachomatous inflammation - follicular) or TF+TI+ (trachomatous inflammation - follicular and intense) on simplified World Health Organisation (WHO) grading system
Exclusion Criteria:
* Trichiasis or corneal opacity;
* palpebral deformation;
* clinically significant ocular abnormality;
* ocular infection;
* organic amblyopia;
* hypersensitivity to treatments' components;
* immunosuppressive conditions;
* systemic AZM or steroids;
* topical ophthalmic antibiotics within 3 months;
* other systemic antibiotics within 1 month;
* topical (ocular, nasal, bronchial etc.) treatments within 1 week;
* systemic non-steroidal anti-inflammatory drugs on day before Day 0
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
10 Years
Study:
NCT00356720
Study Brief:
Protocol Section:
NCT00356720